Injectable Steroid Combination Recalled Due to Sterility Assurance
Talon Compounding Pharmacy is recalling an injectable steroid combination product (Test Cypionate 200mg/Anastrozole 2mg/Dutasteride 2mg/mL) due to lack of assurance of sterility. The affected lot was distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: This is an FDA Class II recall of an injectable product with a sterility defect. Injectable medications with unassured sterility present significant risk of serious infection and potentially require hospitalization; this meets the Severe classification criterion.
Plain-English summary
Vita Pharmacy, LLC dba Talon Compounding Pharmacy is recalling TEST CYPIONATE 200MG/ANASTROZOLE 2MG/DUTASTERIDE 2MG/ML IN OIL INJECTABLE due to lack of assurance of sterility. The recalled product is an Rx-only injectable medication distributed throughout the United States, including Washington, D.C. and Puerto Rico.
The affected lot is T1007142021:50 with a beyond-use date (BUD) of 01/10/2022. Two vials of the product are involved in this recall.
Consumers and healthcare providers who have this product should not use it and should contact Talon Compounding Pharmacy for instructions on return or disposal. Patients currently using this medication should consult their healthcare provider about alternative treatment options.
The recalled product
- Product
- TEST CYPIONATE 200MG/ANASTROZOLE 2MG/DUTASTERIDE 2MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Manufacturer
- Vita Pharmacy, LLC dba Talon Compounding Pharmacy
- Hazard
- sterility-assurance
- bacterial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: T1007142021:50 BUD: 01/10/2022
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27